Almirall and Quintiles, Inc. Sign Long-Term Commercial UK Partnership

LONDON & READING, United Kingdom--(BUSINESS WIRE)--Almirall and Quintiles have reached a long-term strategic partnership agreement to promote Almirall’s respiratory portfolio in the UK commencing with a new, long-acting antimuscarinic (LAMA) delivered via an innovative, multi-dose inhaler for the treatment of chronic obstructive pulmonary disease (COPD).

Back to news